3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Glioma
3
Wilms Tumor
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Neuroepithelial
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Desmoplastic Small Round Cell Tumor
1
Interventions
Thiotepa
3
fludarabine phosphate
2
Melphalan
2
Filgrastim
2
thymoglobulin
1
tanespimycin
1
pembrolizumab
1
omburtamab I-131
1
fludarabine
1
Zoledronic Acid
1
Topotecan
1
Tacrolimus
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mesna
1
Immunologic Techniques
1
Imatinib Mesylate
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Cytoreduction Surgical Procedures
1
Cyclosporins
1
Cyclosporine
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
CLR1404
1
Busulfan
1
Bone Marrow Transplantation
1
Arsenic Trioxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
CLR1404
×
CNS
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled